This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
6-APB: Difference between revisions
>Unity mNo edit summary |
>Josikins No edit summary |
||
| Line 131: | Line 131: | ||
{{DangerousInteractions/SerotoninSyndrome}} | {{DangerousInteractions/SerotoninSyndrome}} | ||
There is an increased risk of serotonin syndrome when 6-APB is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, if 6-APB is taken with SSRIs and SNRIs, the MDMA will be significantly less powerful or may have no distinguishable effects at all. | There is an increased risk of serotonin syndrome when 6-APB is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, if 6-APB is taken with SSRIs and SNRIs, the MDMA will be significantly less powerful or may have no distinguishable effects at all. | ||
==Legal issues== | ==Legal issues== | ||